Russell Investments »

Lineage Cell Therapeutics In shares owned by Russell Investments

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Russell Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 15k 1.31
2022-03-31 $10k 7.0k 1.44
2021-12-31 $17k 7.0k 2.44
2021-09-30 $31k 12k 2.50
2021-06-30 $44k 16k 2.79
2020-06-30 $662k 762k 0.87

More positions owned by Russell Investments

Nvidia Corp Common stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Micron Technology Common Stock (MU)
Taiwan Semiconductor Manufacturing Company Common Stock (TSM)
Meta Platforms Common Stock (META)
Mastercard Incorporated Common Stock (MA)
Advanced Micro Devices Common Stock (AMD)
Eli Lilly And Company Common Stock (LLY)
Tesla Common Stock (TSLA)
Applied Materials Common Stock (AMAT)

View all positions for Russell Investments

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
Morgan Stanley
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
State Street Corporation

View all funds holding Lineage Cell Therapeutics In